|
Volumn 16, Issue 2, 2002, Pages 160-161
|
Retinoic acid syndrome: A problem of the past?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CATHEPSIN G;
CYTARABINE;
DEXAMETHASONE;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
RETINOIC ACID;
STEROID;
ACUTE KIDNEY FAILURE;
ARTICLE;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DYSPNEA;
FEVER;
HUMAN;
HYPOTENSION;
LEUKEMIA REMISSION;
LEUKOCYTE ACTIVATION;
LEUKOCYTE COUNT;
LUNG EDEMA;
LUNG INFILTRATE;
MAJOR CLINICAL STUDY;
PATHOGENESIS;
PERICARDIAL EFFUSION;
PLEURA EFFUSION;
PRIORITY JOURNAL;
PROGNOSIS;
PROMYELOCYTIC LEUKEMIA;
RETINOIC ACID SYNDROME;
THROMBOCYTE COUNT;
ANTINEOPLASTIC AGENTS;
DEXAMETHASONE;
HUMANS;
HYPERTENSION;
INCIDENCE;
KIDNEY FAILURE, ACUTE;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
LEUKOCYTE COUNT;
LEUKOCYTOSIS;
LEUKOSTASIS;
MORTALITY;
PREMEDICATION;
RESPIRATORY DISTRESS SYNDROME, ADULT;
RISK FACTORS;
SYNDROME;
TRETINOIN;
|
EID: 0036169779
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402344 Document Type: Article |
Times cited : (20)
|
References (16)
|